How 23andMe is Helping People Better Understand Their DNA
Market research firm Kalorama Information estimates the consumer market for genetic health testing could triple by 2022. 23andMe's Director of Product Science Shirley Wu explains how the testing company is differentiating itself in this growing market.
"We are the only direct-to-consumer genetic testing company that provides health related information," said Wu. "We believe that everyone has the right to their own DNA information. It's information about you--you should know it if you want to know it."
23andMe CEO Anne Wojcicki has been outspoken about the company's efforts to maintain a gender-equal workforce. "It's been really great to be a part of a company like that where from the beginning we had really strong female leaders who set the vision for the company," says Wu. "There's never been a question of can women hold their own."
Paul Travers, CEO of Vuzix, joins Cheddar News to discuss the different scenarios that its augmented reality smart glasses can be used for and his outlook for this technology in 2022.
This year saw big developments in the sector, including the rise of cryptocurrency, announcements about new metaverse and virtual worlds, increased consumer interest in wearable tech, and more. What does 2022 have in store for these aspects of the tech world, and what else can we expect? Hatem Dhiab, Managing Partner at Gerber Kawasaki, joins Cheddar News' Closing Bell to discuss.
With the rollout of 5G technology, mobile phone users are experiencing faster device performance. But as the tech becomes more widely available, 5G won't just make our phones operate faster. Digital productivity across the board is expected to rise. Hugh Odom, founder and president of Vertical Consultants, joined Cheddar's "Closing Bell" to talk about his company's predictions for 5G, including more streamlined virtual doctor visits and helping supply chains become more efficient. Odom also talked about the airline industry's request to the Biden administration to delay the wider rollout of 5G, as they said it will interfere with flying safety.
Jurors in the trial against Theranos CEO Elizabeth Holmes have entered day six of deliberations. Holmes is accused of lying to investors about the functionality of a newly developed blood-testing technology. Andrew George, partner at Baker Botts, joined Cheddar to break down key points in the case and what the jury might be considering during their deliberations. He also noted that the rest of Silicon Valley, including Holmes' business partner, Ramesh "Sunny" Balwani, who is facing identical charges, is closely watching the outcome of deliberations — as it could set the tone for future regulations and Balwani's own trial.
